Market Tracker

01/30 11:02pm ET

Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

0.73
Data as of Jan 30
 -0.004 / -0.54%
Today’s Change
0.65
Today|||52-Week Range
1.52
+4.29%
Year-to-Date
No recent news for Rexahn Pharmaceuticals Inc.

Today’s Trading

Previous close0.73
Today’s open0.74
Day’s range0.72 - 0.74
Volume471,635
Average volume (3 months)1,024,107
Market cap$130.1M
Dividend yield--
Data as of 4:01pm ET, 01/30/2015

Growth & Valuation

Earnings growth (last year)-16.67%
Earnings growth (this year)-57.14%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book8.48

Competitors

 Today’s
change
Today’s
% change
ADHDAlcobra Ltd-0.22-3.44%
ZSANZosano Pharma Corp-0.11-0.98%
MEIPMEI Pharma Inc+0.08+2.07%
HSKAHeska Corp+1.35+7.28%
Data as of 4:00pm ET, 01/30/2015

Financials

Next reporting dateMarch 23, 2015
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$0.00
Annual profit (last year)-$9.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Scientist
Chang Ho Ahn
Chief Executive Officer &
Director
Peter David Suzdak
Corporate headquarters
Rockville, Maryland

Forecasts